DarioHealth Corp. (NASDAQ:DRIO) Sees Large Increase in Short Interest

DarioHealth Corp. (NASDAQ:DRIO) was the recipient of a significant increase in short interest in the month of December. As of December 15th, there was short interest totalling 2,010,000 shares, an increase of 5.2% from the November 30th total of 1,910,000 shares. Based on an average daily trading volume, of 106,600 shares, the days-to-cover ratio is currently 18.9 days.

Institutional Inflows and Outflows

Several hedge funds and other institutional investors have recently added to or reduced their stakes in DRIO. XTX Topco Ltd lifted its position in shares of DarioHealth by 81.4% in the 3rd quarter. XTX Topco Ltd now owns 29,455 shares of the company’s stock worth $33,000 after purchasing an additional 13,219 shares during the period. Appian Way Asset Management LP lifted its holdings in DarioHealth by 2.5% during the third quarter. Appian Way Asset Management LP now owns 1,410,870 shares of the company’s stock worth $1,580,000 after buying an additional 34,990 shares during the period. Finally, DLK Investment Management LLC boosted its position in DarioHealth by 71.6% during the 3rd quarter. DLK Investment Management LLC now owns 100,550 shares of the company’s stock valued at $113,000 after acquiring an additional 41,943 shares in the last quarter. 33.39% of the stock is currently owned by institutional investors.

DarioHealth Price Performance

Shares of DRIO stock opened at $0.79 on Thursday. The company has a market capitalization of $26.80 million, a P/E ratio of -0.84 and a beta of 1.47. The company has a debt-to-equity ratio of 0.35, a current ratio of 1.57 and a quick ratio of 1.32. DarioHealth has a one year low of $0.63 and a one year high of $2.60. The company’s 50-day simple moving average is $0.80 and its two-hundred day simple moving average is $0.95.

About DarioHealth

DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.